RUBIUS THERAPEUTICS, INC.: cash_and_equivalents
| Value | {"amount": 225848000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | RUBIUS THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:29:57.340308+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/c2b4a274-40f9-4119-b8e3-ace715211fed
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-22-002057Retrieved: 2026-08-19T17:29:57.340308+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001709401/cash-and-equivalents/2021-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/c2b4a274-40f9-4119-b8e3-ace715211fed
History
- no predecessors — first report